1210 related articles for article (PubMed ID: 18277902)
1. Risk factors of peptic ulcer in 4943 inpatients.
Talamini G; Tommasi M; Amadei V; Pajusco B; Fratucello A; Lechi A; Scroccaro G; Vantini I
J Clin Gastroenterol; 2008 Apr; 42(4):373-80. PubMed ID: 18277902
[TBL] [Abstract][Full Text] [Related]
2. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
3. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
Karateev AE; Nasonova VA
Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
[TBL] [Abstract][Full Text] [Related]
4. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
[TBL] [Abstract][Full Text] [Related]
5. [Epidemiology and risk factors of gastroduodenal ulcer].
Kreiss C; Blum AL
Chirurg; 1996 Jan; 67(1):7-13. PubMed ID: 8851669
[TBL] [Abstract][Full Text] [Related]
6. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
7. [Incidence of peptic ulcer at the Instituto Nacional de la Nutrición "Salvador Zubirán": study of localization, associated factors and temporal trends].
Bobadilla J; Vargas-Vorácková F; Gómez A; Jesús Villalobos J
Rev Gastroenterol Mex; 1996; 61(1):31-5. PubMed ID: 8685587
[TBL] [Abstract][Full Text] [Related]
8. Clinical trends in ulcer diagnosis in a population with high prevalence of Helicobacter pylori infection.
Pérez-Aisa MA; Del Pino D; Siles M; Lanas A
Aliment Pharmacol Ther; 2005 Jan; 21(1):65-72. PubMed ID: 15644047
[TBL] [Abstract][Full Text] [Related]
9. Time-trends in the epidemiology of peptic ulcer bleeding.
Ohmann C; Imhof M; Ruppert C; Janzik U; Vogt C; Frieling T; Becker K; Neumann F; Faust S; Heiler K; Haas K; Jurisch R; Wenzel EG; Normann S; Bachmann O; Delgadillo J; Seidel F; Franke C; Lüthen R; Yang Q; Reinhold C
Scand J Gastroenterol; 2005 Aug; 40(8):914-20. PubMed ID: 16165708
[TBL] [Abstract][Full Text] [Related]
10. Ulcers and gastritis.
Kashiwagi H
Endoscopy; 2003 Jan; 35(1):9-14. PubMed ID: 12510220
[TBL] [Abstract][Full Text] [Related]
11. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study.
Lassen A; Hallas J; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2006 May; 101(5):945-53. PubMed ID: 16573778
[TBL] [Abstract][Full Text] [Related]
12. A multicenter, randomized, double-blind, active-comparator, placebo-controlled, parallel-group comparison of the incidence of endoscopic gastric and duodenal ulcer rates with valdecoxib or naproxen in healthy subjects aged 65 to 75 years.
Goldstein JL; Aisenberg J; Lanza F; Schwartz H; Sands GH; Berger MF; Pan S
Clin Ther; 2006 Mar; 28(3):340-51. PubMed ID: 16750449
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic follow-up of gastric ulcer in a population at intermediate risk for gastric cancer.
Mañas MD; Domper A; Albillos A; Hernández A; Carpintero P; Lorente R; López B; De la Santa E; Olmedo J; Rodríguez E
Rev Esp Enferm Dig; 2009 May; 101(5):317-24. PubMed ID: 19527077
[TBL] [Abstract][Full Text] [Related]
14. Peptic ulcer disease in the elderly.
Cryer B; Feldman M
Semin Gastrointest Dis; 1994 Oct; 5(4):166-78. PubMed ID: 7834250
[No Abstract] [Full Text] [Related]
15. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
16. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with gastro-duodenal disease in patients undergoing upper GI endoscopy at the Korle-Bu Teaching Hospital, Accra, Ghana.
Archampong TN; Asmah RH; Wiredu EK; Gyasi RK; Nkrumah KN
Afr Health Sci; 2016 Jun; 16(2):611-9. PubMed ID: 27605979
[TBL] [Abstract][Full Text] [Related]
18. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease.
Wu CY; Kuo KN; Wu MS; Chen YJ; Wang CB; Lin JT
Gastroenterology; 2009 Nov; 137(5):1641-8.e1-2. PubMed ID: 19664631
[TBL] [Abstract][Full Text] [Related]
19. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications.
Goldstein JL; Howard KB; Walton SM; McLaughlin TP; Kruzikas DT
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1337-45. PubMed ID: 17088110
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the effects of diclofenac or other non-steroidal anti-inflammatory drugs (NSAIDs) and diclofenac or other NSAIDs in combination with proton pump inhibitors (PPI) on hospitalisation due to peptic ulcer disease.
Höer A; Gothe H; Schiffhorst G; Sterzel A; Grass U; Häussler B
Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):854-8. PubMed ID: 17323403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
